• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无功能性垂体瘤

Nonfunctioning pituitary tumors.

作者信息

Molitch Mark E

机构信息

Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Handb Clin Neurol. 2014;124:167-84. doi: 10.1016/B978-0-444-59602-4.00012-5.

DOI:10.1016/B978-0-444-59602-4.00012-5
PMID:25248587
Abstract

Clinically nonfunctioning adenomas range from being completely asymptomatic, and therefore detected either at autopsy or as incidental findings on head MRI or CT scans performed for other reasons, to causing significant hypothalamic/pituitary dysfunction and visual field compromise due to their large size. Patients with incidental adenomas should be screened for hypersecretion (prolactin, insulin-like growth factor 1, midnight salivary cortisol) and for hypopituitarism (macroadenomas). In the absence of hypersecretion, hypopituitarism, or visual field defects, patients may be followed by periodic screening by MRI for enlargement, at which point surgery may be necessary. Symptomatic patients with clinically nonfunctioning adenomas are generally treated by transsphenoidal surgery. Postoperative MRIs are done at 3-4 months after surgery to assess for completeness of resection and then repeated yearly for 3-5 years and subsequently less frequently to assess for regrowth. For those with no visible tumor on MRI, the tumor regrowth rate is about 13% and such patients may be followed with periodic MRIs. For those with visible tumor, the tumor regrowth rate is about 40%. This regrowth rate may be substantially reduced with the use of dopamine agonists and radiotherapy.

摘要

临床上无功能腺瘤的表现范围很广,从完全无症状(因此在尸检时发现,或因其他原因进行头部磁共振成像(MRI)或计算机断层扫描(CT)时偶然发现)到因体积巨大导致明显的下丘脑/垂体功能障碍和视野受损。偶然发现腺瘤的患者应筛查激素分泌过多情况(催乳素、胰岛素样生长因子1、午夜唾液皮质醇)和垂体功能减退情况(大腺瘤)。在没有激素分泌过多、垂体功能减退或视野缺损的情况下,患者可通过定期MRI检查监测腺瘤是否增大,必要时可能需要进行手术。有症状的临床上无功能腺瘤患者一般采用经蝶窦手术治疗。术后在3至4个月进行MRI检查以评估切除的完整性,然后在3至5年内每年重复检查,随后检查频率降低以评估肿瘤是否复发。对于MRI上无可见肿瘤的患者,肿瘤复发率约为13%,此类患者可定期进行MRI检查。对于有可见肿瘤的患者,肿瘤复发率约为40%。使用多巴胺激动剂和放疗可能会大幅降低这种复发率。

相似文献

1
Nonfunctioning pituitary tumors.无功能性垂体瘤
Handb Clin Neurol. 2014;124:167-84. doi: 10.1016/B978-0-444-59602-4.00012-5.
2
Nonfunctioning pituitary tumors and pituitary incidentalomas.无功能垂体瘤和垂体偶发瘤。
Endocrinol Metab Clin North Am. 2008 Mar;37(1):151-71, xi. doi: 10.1016/j.ecl.2007.10.011.
3
Pituitary tumours: pituitary incidentalomas.垂体肿瘤:垂体偶发瘤。
Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):667-75. doi: 10.1016/j.beem.2009.05.001.
4
Management of incidentally found nonfunctional pituitary tumors.偶然发现的无功能性垂体瘤的处理。
Neurosurg Clin N Am. 2012 Oct;23(4):543-53. doi: 10.1016/j.nec.2012.06.003. Epub 2012 Jul 31.
5
Management of nonfunctioning pituitary adenomas (NFAs): observation.无功能性垂体腺瘤(NFAs)的治疗:观察。
Pituitary. 2018 Apr;21(2):162-167. doi: 10.1007/s11102-017-0856-0.
6
Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.术中高场强磁共振成像用于无功能垂体腺瘤经蝶窦再次手术
J Neurosurg. 2014 Nov;121(5):1166-75. doi: 10.3171/2014.6.JNS131994. Epub 2014 Aug 15.
7
Imaging of pituitary pathology.垂体病变的影像学检查。
Handb Clin Neurol. 2014;124:151-66. doi: 10.1016/B978-0-444-59602-4.00011-3.
8
Diagnosis and Treatment of Pituitary Adenomas: A Review.垂体腺瘤的诊断与治疗:综述
JAMA. 2017 Feb 7;317(5):516-524. doi: 10.1001/jama.2016.19699.
9
Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas.临床无功能垂体大腺瘤的治疗与随访
J Clin Endocrinol Metab. 2008 Oct;93(10):3717-26. doi: 10.1210/jc.2008-0643. Epub 2008 Aug 5.
10
Pituitary adenomas: an overview.垂体腺瘤:概述。
Am Fam Physician. 2013 Sep 1;88(5):319-27.

引用本文的文献

1
Multidisciplinary management of pituitary macroadenoma.垂体大腺瘤的多学科管理
World J Methodol. 2025 Sep 20;15(3):97694. doi: 10.5662/wjm.v15.i3.97694.
2
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.垂体偶发瘤:一项垂体协会国际共识指南声明
Nat Rev Endocrinol. 2025 Jun 24. doi: 10.1038/s41574-025-01134-8.
3
Comparative analysis of the effects of microscopic vs. neuroendoscopic transsphenoidal surgery on visual and pituitary function and postoperative recurrence factors in patients with pituitary tumors.
垂体瘤患者中显微镜下与神经内镜经蝶窦手术对视力和垂体功能的影响及术后复发因素的比较分析
Am J Transl Res. 2025 Mar 15;17(3):1728-1741. doi: 10.62347/PUQA6181. eCollection 2025.
4
Pituitary adenomas: biology, nomenclature and clinical classification.垂体腺瘤:生物学、命名法及临床分类
Rev Endocr Metab Disord. 2025 Apr;26(2):137-146. doi: 10.1007/s11154-025-09944-x. Epub 2025 Jan 25.
5
Stereotactic radiosurgery for recurrent/residual nonfunctioning pituitary adenoma: a single-arm systematic review and meta-analysis.立体定向放射外科治疗复发性/残留无功能垂体腺瘤:一项单臂系统评价和荟萃分析。
Acta Neurochir (Wien). 2024 Oct 2;166(1):392. doi: 10.1007/s00701-024-06296-4.
6
Pituitary Neuroendocrine Tumor: Is It Benign or Malignant?垂体神经内分泌肿瘤:它是良性还是恶性?
Brain Tumor Res Treat. 2023 Jul;11(3):173-176. doi: 10.14791/btrt.2023.0015.
7
The Value of Intraoperative Magnetic Resonance Imaging in Endoscopic Endonasal Resection of Pituitary Adenoma.术中磁共振成像在经鼻内镜垂体腺瘤切除术中的价值
J Neurol Surg B Skull Base. 2022 Sep 28;83(6):646-652. doi: 10.1055/a-1924-8166. eCollection 2022 Dec.
8
Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?无功能性垂体腺瘤初始手术后的管理:监测、放疗还是手术?
Radiat Oncol. 2022 Oct 13;17(1):165. doi: 10.1186/s13014-022-02133-z.
9
An Overview of Pituitary Incidentalomas: Diagnosis, Clinical Features, and Management.垂体意外瘤概述:诊断、临床特征及管理
Cancers (Basel). 2022 Sep 3;14(17):4324. doi: 10.3390/cancers14174324.
10
Clinical Biology of the Pituitary Adenoma.垂体腺瘤的临床生物学。
Endocr Rev. 2022 Nov 25;43(6):1003-1037. doi: 10.1210/endrev/bnac010.